Kyriakakis E - Search Results

1

EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.

Maslova K, Kyriakakis E, Pfaff D, Frachet A, Frismantiene A, Bubendorf L, Ruiz C, Vlajnic T, Erne P, Resink TJ, Philippova M. Maslova K, et al. Among authors: kyriakakis e. FASEB J. 2015 Feb;29(2):494-507. doi: 10.1096/fj.14-249367. Epub 2014 Nov 7. FASEB J. 2015. PMID: 25381040

2

A guide and guard: the many faces of T-cadherin.

Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ. Philippova M, et al. Among authors: kyriakakis e. Cell Signal. 2009 Jul;21(7):1035-44. doi: 10.1016/j.cellsig.2009.01.035. Cell Signal. 2009. PMID: 19399994 Review.

3

Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells.

Joshi MB, Kyriakakis E, Pfaff D, Rupp K, Philippova M, Erne P, Resink TJ. Joshi MB, et al. Among authors: kyriakakis e. FASEB J. 2009 Nov;23(11):4011-21. doi: 10.1096/fj.09-133611. Epub 2009 Jul 28. FASEB J. 2009. PMID: 19638398

4

T-Cadherin is an auxiliary negative regulator of EGFR pathway activity in cutaneous squamous cell carcinoma: impact on cell motility.

Kyriakakis E, Maslova K, Philippova M, Pfaff D, Joshi MB, Buechner SA, Erne P, Resink TJ. Kyriakakis E, et al. J Invest Dermatol. 2012 Sep;132(9):2275-85. doi: 10.1038/jid.2012.131. Epub 2012 May 17. J Invest Dermatol. 2012. PMID: 22592160 Free article.

5

T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.

Philippova M, Pfaff D, Kyriakakis E, Buechner SA, Iezzi G, Spagnoli GC, Schoenenberger AW, Erne P, Resink TJ. Philippova M, et al. Among authors: kyriakakis e. Eur J Cancer. 2013 May;49(8):2048-58. doi: 10.1016/j.ejca.2012.12.026. Epub 2013 Jan 29. Eur J Cancer. 2013. PMID: 23369463

6

Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts.

Kyriakakis E, Maslova K, Frachet A, Ferri N, Contini A, Pfaff D, Erne P, Resink TJ, Philippova M. Kyriakakis E, et al. Cell Signal. 2013 May;25(5):1044-53. doi: 10.1016/j.cellsig.2013.02.001. Epub 2013 Feb 11. Cell Signal. 2013. PMID: 23411345

7

A requirement for thioredoxin in redox-sensitive modulation of T-cadherin expression in endothelial cells.

Joshi MB, Ivanov D, Philippova M, Kyriakakis E, Erne P, Resink TJ. Joshi MB, et al. Among authors: kyriakakis e. Biochem J. 2008 Dec 1;416(2):271-80. doi: 10.1042/BJ20080765. Biochem J. 2008. PMID: 18627351

8

Cadherins and cardiovascular disease.

Resink TJ, Philippova M, Joshi MB, Kyriakakis E, Erne P. Resink TJ, et al. Among authors: kyriakakis e. Swiss Med Wkly. 2009 Mar 7;139(9-10):122-34. doi: 10.4414/smw.2009.12429. Swiss Med Wkly. 2009. PMID: 19274489 Free article. Review.

9

T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis.

Kyriakakis E, Philippova M, Joshi MB, Pfaff D, Bochkov V, Afonyushkin T, Erne P, Resink TJ. Kyriakakis E, et al. Cell Signal. 2010 Sep;22(9):1308-16. doi: 10.1016/j.cellsig.2010.04.008. Epub 2010 May 8. Cell Signal. 2010. PMID: 20457250

10

T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis.

Philippova M, Suter Y, Toggweiler S, Schoenenberger AW, Joshi MB, Kyriakakis E, Erne P, Resink TJ. Philippova M, et al. Among authors: kyriakakis e. Eur Heart J. 2011 Mar;32(6):760-71. doi: 10.1093/eurheartj/ehq206. Epub 2010 Jun 28. Eur Heart J. 2011. PMID: 20584775 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters